Last update 01 Nov 2024

KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3

Basic Info

Related Targets
KLK2HOXB13NKX3-1[+2]

Related

1
Drugs associated with KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3
WP1 cancer vaccine(BioNTech SE)
Target
ACP3 x HOXB13 x KLK2 x KLK3 x NKX3-1
Mechanism
ACP3 inhibitors [+4]
Active Org.-
Originator Org.
BioNTech SEBioNTech SE
Active Indication-
Inactive Indication-
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3
NCT04382898 / TerminatedPhase 1/2
First-in-human, Dose Titration and Expansion Trial to Evaluate Safety, Immunogenicity and Preliminary Efficacy of W_pro1 (BNT112) Monotherapy and in Combination With Cemiplimab in Patients With Prostate Cancer
100 Clinical Results associated with KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3
Login to view more data
100 Translational Medicine associated with KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3
Login to view more data
0 Patents (Medical) associated with KLK2 x HOXB13 x NKX3-1 x ACP3 x KLK3
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free